SNN

Smith & Nephew plc
D

SNN

28.120
USD
-0.06
(-0.21%)
مغلق
حجم التداول
18,211
الربح لكل سهم
2
العائد الربحي
2.66
P/E
30
حجم السوق
12,281,552,062
أصول ذات صلة
ABT
ABT
0.240
(0.18%)
131.910 USD
BAX
BAX
-0.400
(-1.18%)
33.630 USD
BDX
BDX
0.385
(0.17%)
226.395 USD
BSX
BSX
-1.220
(-1.20%)
100.030 USD
EW
EW
0.150
(0.21%)
72.040 USD
ILMN
ILMN
3.480
(4.44%)
81.820 USD
ISRG
ISRG
10.91
(2.20%)
507.00 USD
MDT
MDT
0.350
(0.40%)
88.860 USD
PODD
PODD
6.05
(2.30%)
269.21 USD
TMO
TMO
6.11
(1.27%)
489.04 USD
المزيد
الأخبار المقالات

العنوان: Smith & Nephew plc

القطاع: Healthcare
الصناعة: Medical Devices
Smith & Nephew designs, manufactures, and markets orthopedic devices, sports medicine and arthroscopic technologies, and wound care solutions. Roughly 41% of the UK-based firm's revenue comes from orthopedic products, and another 30% is sports medicine and ENT. The remaining 29% of revenue is from the advanced wound therapy segment. Over half of Smith & Nephew's total revenue comes from the United States, just over 30% is from other developed markets, and emerging markets account for the remainder.